MERRIMACK PHARMACEUTICALS INC Repayments of Long-Term Debt
MERRIMACK PHARMACEUTICALS INC reported Repayments of Long-Term Debt of $56.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2021-11-04
- MERRIMACK PHARMACEUTICALS INC repayments of long-term debt for the quarter ending 2019-12-31 was $0.00.
- MERRIMACK PHARMACEUTICALS INC repayments of long-term debt for the quarter ending 2019-09-30 was $0.00.
- MERRIMACK PHARMACEUTICALS INC repayments of long-term debt for the quarter ending 2017-12-31 was $54.66M.
- MERRIMACK PHARMACEUTICALS INC repayments of long-term debt for the quarter ending 2017-09-30 was $0.00.
- MERRIMACK PHARMACEUTICALS INC repayments of long-term debt for fiscal 2019 was $15.00M.
- MERRIMACK PHARMACEUTICALS INC repayments of long-term debt for fiscal 2017 was $229.66M.
- MERRIMACK PHARMACEUTICALS INC repayments of long-term debt for fiscal 2015 was $40.00M.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2020-09-30 | $56.00K 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $0.00 derived: sum of 2 quarters · filed 2021-03-10 | $15.00M 10-K · filed 2021-03-10 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $15.00M 10-Q · filed 2020-11-04 | ||
| 2019-06-30 | $15.00M 10-Q · filed 2020-08-07 | |||
| 2017-12-31 | $54.66M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $54.66M derived: sum of 2 quarters · filed 2019-03-06 | $229.66M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $175.00M 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | $175.00M 10-Q · filed 2018-08-07 | |||
| 2015-12-31 | $40.00M 10-K · filed 2018-03-12 |